(19)
(11) EP 4 436 563 A1

(12)

(43) Date of publication:
02.10.2024 Bulletin 2024/40

(21) Application number: 22826058.4

(22) Date of filing: 24.11.2022
(51) International Patent Classification (IPC): 
A61K 31/196(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/196; A61P 31/14
(86) International application number:
PCT/EP2022/083197
(87) International publication number:
WO 2023/094556 (01.06.2023 Gazette 2023/22)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 24.11.2021 EP 21210256

(71) Applicant: Atriva Therapeutics GmbH
72072 Tübingen (DE)

(72) Inventors:
  • PLANZ, Oliver
    72581 Dettingen an der Erms (DE)
  • FÜLL, Yvonne
    72072 Tuebingen (DE)

(74) Representative: Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB 
Ganghoferstraße 68 B
80339 München
80339 München (DE)

   


(54) MEK INHIBITORS FOR THE PREVENTION AND TREATMENT OF LONG COVID SYNDROME